verapamil has been researched along with Genetic Predisposition in 4 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Management of MdDS as vestibular migraine can improve patients' symptoms and increase the QOL." | 1.46 | Management of mal de debarquement syndrome as vestibular migraines. ( Bhatt, J; Djalilian, HR; Ghavami, Y; Haidar, YM; Lin, HW; Moshtaghi, O; Ziai, KN, 2017) |
| " Incidents of adverse cardiac drug reactions are more common in patients with preexisting heart disease than the general population." | 1.39 | Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. ( Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, P | 1 |
| Lan, F | 1 |
| Lee, AS | 1 |
| Gong, T | 1 |
| Sanchez-Freire, V | 1 |
| Wang, Y | 1 |
| Diecke, S | 1 |
| Sallam, K | 1 |
| Knowles, JW | 1 |
| Wang, PJ | 1 |
| Nguyen, PK | 1 |
| Bers, DM | 1 |
| Robbins, RC | 1 |
| Wu, JC | 1 |
| Ghavami, Y | 1 |
| Haidar, YM | 1 |
| Ziai, KN | 1 |
| Moshtaghi, O | 1 |
| Bhatt, J | 1 |
| Lin, HW | 1 |
| Djalilian, HR | 1 |
| Kullmann, S | 1 |
| Binner, P | 1 |
| Rackebrandt, K | 1 |
| Huge, A | 1 |
| Haltern, G | 1 |
| Lankisch, M | 1 |
| Füth, R | 1 |
| von Hodenberg, E | 1 |
| Bestehorn, HP | 1 |
| Scheffold, T | 1 |
| Papp, AC | 1 |
| Pinsonneault, JK | 1 |
| Wang, D | 1 |
| Newman, LC | 1 |
| Gong, Y | 1 |
| Johnson, JA | 1 |
| Pepine, CJ | 1 |
| Kumari, M | 1 |
| Hingorani, AD | 1 |
| Talmud, PJ | 1 |
| Shah, S | 1 |
| Humphries, SE | 1 |
| Sadee, W | 1 |
1 trial available for verapamil and Genetic Predisposition
| Article | Year |
|---|---|
Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Case-Control Studies; Coronar | 2009 |
3 other studies available for verapamil and Genetic Predisposition
| Article | Year |
|---|---|
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentia | 2013 |
Management of mal de debarquement syndrome as vestibular migraines.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fructose; Genetic Predisposition to Disease; Humans; | 2017 |
Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk.
Topics: Adult; Alleles; Atenolol; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, | 2012 |